MedPath

Pre Injection Use of Cryoanesthesia Versus Topical Anesthetic Gel in Reducing Pain Perception During Palatal Injections

Phase 4
Completed
Conditions
Pain
Interventions
Other: Topical ice
Registration Number
NCT06165432
Lead Sponsor
B.P. Koirala Institute of Health Sciences
Brief Summary

The goal of this interventional study is to assess the effectiveness of pre-injection use of topical ice application in decreasing pain perception when administering greater palatine nerve block injections as compared to that of topical 20 % benzocaine anesthetic gel using Visual Analogue Scale (VAS) for subjective pain assessment and Sound, Eye, Motor (SEM) scale for objective pain assessment in adult patients.

The main question it aims to answer are:

1. Does topical cooling reduce pain as effectively as topical benzocaine during greater palatine nerve block injections?

2. Is there any adverse reactions during and after application of topical ice and 20 % benzocaine gel?

3. Is there any difference in patient acceptability to the use of either methods during the administration of greater palatine nerve block.

A split mouth design was used where an anesthetic injection was administered in the left and right posterior palatal area. The same operator administered the injections so as to standardize the flow rate and delivery style. The method of intervention i.e topical ice or topical 20% benzocaine anesthetic gel was randomly allocated to the patient by lottery method. The participants received two palatal injections with an interval of two weeks between the appointments. The subjective pain response of the patients during greater palatine nerve block injection with pre-injection use of topical ice and topical anesthetic gel (20% benzocaine) was recorded using VAS scale. The objective pain response of the patients were recorded by a blinded single observer using SEM scale on the same day of the appointment.

Technique of application of topical ice: A new pack of sterile cotton swabstick that was injected with 0.5ml commercially available bottled water and then freezed the day before the appointment. At the time of intervention the injection site was dried with gauge piece and the frozen cotton swab stick was held by its wooden part and the frozen cotton end was placed on the proposed anesthetic site (palatal mucosa just anterior to the greater palatine foramen) for 1 minute. With the frozen cotton swabstick in place, an injection of 0.5 mL of 2 percent Lidocaine with 1:200,000 epinephrine was administered into the injection site via a 27-gauge short needle.

Technique of application of topical anesthetic gel: After the oral mucosa was dried with a gauze piece, application of 0.2 mL Benzocaine 20% gel was done with a sterile swab stick on the proposed anesthetic site (palatal mucosa just anterior to the greater palatine foramen) for a period of two minutes as shown in figure. With the cotton swabstick in place an injection of 0.5 mL of 2 percent Lidocaine with 1:200,000 epinephrine was administered into the injection site via a 27-gauge short needle.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Clinically healthy patients ASA I and ASA II with intact palatal mucosa on both sides
  • Procedures that needs administration of greater palatine nerve block
Exclusion Criteria
  • Hypersensitivity to local anesthetic agent
  • Patient who are physically and mentally sub normal
  • Presence of palatal mucosal lesions
  • Patients on long term neuromodulators for chronic pain
  • Patient not consenting to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Drug Arm :Topical benzocaineTopical Benzocainesince its a split mouth study one half of the hard palate will receive topical benzocaine i.e Group A
Topical iceTopical iceOther half of the palate will receive topical ice i.e Group B
Primary Outcome Measures
NameTimeMethod
subjective pain perception during greater palatine nerve block injectionImmediatley after the injection

measured using Visual analogue Scale (VAS) - The Visual Analogue Scale (VAS) consisting of a 100 mm straight line with the endpoints marked to denote extreme limits on the left as 'no pain at all' and on the right as 'pain as bad as it could be' was used to record the pain score . The patient was asked to mark their pain level on the line between the two endpoints after receiving the palatal injection. The distance between 'no pain at all' and the mark defined the subject's pain which was measured in millimeters.

objective pain perception during greater palatine nerve block injectionDuring the injection procedure

measured using Sound, Eye and Motor (SEM) scale -The SEM scale was used in the assessment of the relationship between pain and the reactions which the sensation of pain generates in the patient's eyes, bodily movements and verbal expressions of discomfort

Secondary Outcome Measures
NameTimeMethod
Adverse effectsupto 30 minutes after the injection

Immediate adverse side effects like burning/stinging sensation, local hypersensitivity reaction (urticaria, erythema, itching) and immediate systemic effects (dizziness, drowsiness, palpitations) were assessed; marked as 0: absent and 1: present.

Acceptability regarding the use of either topical ice or topical benzocaine5 minutes after application

The overall patient perception regarding the use of topical ice and topical benzocaine as a preanesthetic agent was assessed using a 5 point Likert scale containing 5 response options that consisted of two extreme sides and a neutral option.

The five response options were: 1.Very bad, 2 Bad, 3. satisfactory 4. Good and 5. Very Good

Trial Locations

Locations (1)

B.P Koirala institute of health sciences

šŸ‡³šŸ‡µ

Dharān Bāzār, Koshi, Nepal

Ā© Copyright 2025. All Rights Reserved by MedPath